Skip to main content

Deck.blue brings a TweetDeck experience to Bluesky users

With over 3 million users and plans to open up more broadly in the months ahead, Bluesky is still establishing itself as an alternative to Twitter/X. However, that hasn’t stopped the developer community from embracing the project and building tools to meet the needs of those fleeing the now Elon Musk-owned social network, formerly known […] © 2024 TechCrunch. All rights reserved. For personal use only. from TechCrunch https://ift.tt/TBbEAPF
Post a Comment

The cultivated meat industry’s known struggles will take time to sort out, and maybe that’s OK

The Wall Street Journal went under the hood of the lab-grown meat industry, also known as cultivated or cell-cultured meat, and the struggles within.

The Journal particularly homed in on what’s going on at UPSIDE Foods, which received a blessing from the U.S. Food and Drug Administration related to its process for making cultivated chicken, essentially saying it was safe to eat and making it the first company to receive this approval. Eat Just, which has been selling its product in Singapore, the first nation to approve the sale of cultivated meat, followed, getting its “thumbs-up” from the FDA in March.

WSJ’s story pays particular attention to UPSIDE Foods’ success at making small batches of its chicken product, as well as its lack of being able to produce large amounts of product at a low cost, or at even price parity with traditional meat — and to be fair, most cultivated meat companies struggle with this too.

“Initially our chicken will be sold at a price premium,” UPSIDE founder and CEO Uma Valeti told TechCrunch in November. “As we scale, we expect to eventually reach price parity with conventionally produced meat. Our goal is to ultimately be more affordable than conventionally produced meat.”

UPSIDE Foods bites into $400M round to serve cultivated meat later this year

Companies in this sector make meat from animal cells that are fed growth factors. The production and pricing challenges presented in the WSJ story, however, are not new. “Is cell-culture meat ready for prime time?” wasn’t just a clever TechCrunch+ headline, but a legitimate question posed in early 2022 that still really hasn’t been answered.

Most cultivated meat stories in our archives include at least a sentence about how hard it is for companies to produce mass quantities and to create foods by this method so that the finished product is under $10 a pound.

The cultivated meat industry’s known struggles will take time to sort out, and maybe that’s OK by Christine Hall originally published on TechCrunch



from TechCrunch https://ift.tt/jm2KUbe
Labels:

Comments

Post a Comment

Popular posts from this blog

A judge dismissed Phhhoto’s antitrust suit against Meta

A U.S. District Court Judge for the Eastern District of New York threw out a lawsuit against Meta this week that had been simmering for a year and a half. The suit, filed in late 2021 by now-shuttered social app Phhhoto, alleged that Meta violated federal antitrust law by copying its core features with the Instagram-adjacent video looping app Boomerang . Like Boomerang, which Meta launched in October of 2015 and later integrated into Instagram itself, Phhhoto invited users to share very short GIF-like loops. U.S. District Judge Kiyo Matsumoto ultimately granted Meta’s motion to dismiss the complaint due to time-limits imposed by the relevant statutes of limitations. “Phhhoto has failed in its 69-page Amended Complaint of 222 paragraphs to allege sufficient facts that cure the untimeliness of all of its federal claims,” Matsumoto wrote in the opinion, calling the possibility of any amendment to resolve the issue of the lawsuit’s timing “futile.” New antitrust suit from Phhhoto a...
Post a Comment
Read more

6 VCs explain why embedded insurance isn’t the only hot opportunity in insurtech

If you think embedded insurance is the only hot thing in insurtech these days, we’ve got a surprise in store for you: While it’s true that startups that help sell insurance together with other products and services are enjoying tailwinds, there are plenty of other opportunities in the space, several investors told TechCrunch+. You see, insurtech startups often need to take into account the myriad rules and regulations in place when they seek to innovate and embed insurance into products, which might make it difficult to pull it off. And given the current emphasis on achieving cost efficiency to extend runways in the broader startup ecosystem, it appears investors are open to insurtech startups that can build a sustainable business model, regardless of it including embedded insurance. “Insurtech startups that do not offer embedded insurance, and rather provide other innovative solutions will still attract VC funding this year, especially if they can show cost-efficient and sustainabl...
Post a Comment
Read more

Ivella is the latest fintech focused on couples banking, with a twist

Money can make people moody. There are layers of privilege, or lack thereof, that can make even the simplest conversation about bills feel like baggage to deal with. Translate that discomfort to relationships and it can feel like an awkward — and fragmented — dance on who pays which bill when (and how). Ivella , a Santa Monica-based startup, wants to build banking products for couples to take away some of these tensions. Led by CEO and co-founder Kahlil Lalji , the startup is launching with a split account product that just raised $3.5 million in funding from Anthemis, Financial Venture Studio and Soma Capital. Other investors include Y Combinator, DoNotPay CEO Joshua Browder and Gumroad CEO Sahil Lavingia. Lalji, who helped creators with digital content before jumping into the world of fintech, says that the startup was born out of his own frustration at the expectation that couples would just use Venmo unless they were married. The best solution, so far, has been joint accounts...
Post a Comment
Read more